International Journal of Cancer Management

Published by: Kowsar

An In silico Chimeric Vaccine Targeting Breast Cancer Containing Inherent Adjuvant

Abbas Ali Imani Fooladi 1 , Hamideh Mahmoodzadeh Hosseini 1 and Jafar Amani 1 , *
Authors Information
1 Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: May 28, 2015, 8 (3); e2326
  • Published Online: May 22, 2015
  • Article Type: Research Article
  • Received: September 29, 2014
  • Revised: November 16, 2014
  • Accepted: December 14, 2014
  • DOI: 10.17795/ijcp2326

To Cite: Imani Fooladi A A, Mahmoodzadeh Hosseini H, Amani J. An In silico Chimeric Vaccine Targeting Breast Cancer Containing Inherent Adjuvant , Int J Cancer Manag. 2015 ; 8(3):e2326. doi: 10.17795/ijcp2326.

Copyright © 2015, Iranian Journal of Cancer Prevention.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-917[DOI][PubMed]
  • 2. Lanari C, Wargon V, Rojas P, Molinolo AA. Antiprogestins in breast cancer treatment: are we ready? Endocr Relat Cancer. 2012; 19(3)-50[DOI][PubMed]
  • 3. Soto-Cerrato V, Llagostera E, Montaner B, Scheffer GL, Perez-Tomas R. Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin. Biochem Pharmacol. 2004; 68(7): 1345-52[DOI][PubMed]
  • 4. Forrester WC, Dell M, Perens E, Garriga G. A C. elegans Ror receptor tyrosine kinase regulates cell motility and asymmetric cell division. Nature. 1999; 400(6747): 881-5[DOI][PubMed]
  • 5. Rebagay G, Yan S, Liu C, Cheung NK. ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy. Front Oncol. 2012; 2: 34[DOI][PubMed]
  • 6. Al-Shawi R, Ashton SV, Underwood C, Simons JP. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev Genes Evol. 2001; 211(4): 161-71[PubMed]
  • 7. Baskar S, Kwong KY, Hofer T, Levy JM, Kennedy MG, Lee E, et al. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia. Clin Cancer Res. 2008; 14(2): 396-404[DOI][PubMed]
  • 8. Shabani M, Asgarian-Omran H, Vossough P, Sharifian RA, Faranoush M, Ghragozlou S, et al. Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia. Leuk Lymphoma. 2008; 49(7): 1360-7[DOI][PubMed]
  • 9. Gentile A, Lazzari L, Benvenuti S, Trusolino L, Comoglio PM. Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis. Cancer Res. 2011; 71(8): 3132-41[DOI][PubMed]
  • 10. Zhang S, Chen L, Cui B, Chuang HY, Yu J, Wang-Rodriguez J, et al. ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth. PLoS One. 2012; 7(3)[DOI][PubMed]
  • 11. Fooladi AA, Sattari M, Hassan ZM, Mahdavi M, Azizi T, Horii A. In vivo induction of necrosis in mice fibrosarcoma via intravenous injection of type B staphylococcal enterotoxin. Biotechnol Lett. 2008; 30(12): 2053-9[DOI][PubMed]
  • 12. Perabo FG, Willert PL, Wirger A, Schmidt DH, Wardelmann E, Sitzia M, et al. Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer. Int J Cancer. 2005; 115(4): 591-8[DOI][PubMed]
  • 13. Sen TZ, Jernigan RL, Garnier J, Kloczkowski A. GOR V server for protein secondary structure prediction. Bioinformatics. 2005; 21(11): 2787-8[DOI][PubMed]
  • 14. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008; 9: 40[DOI][PubMed]
  • 15. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl Crystal. 1993; 26(2): 283-91
  • 16. El-Manzalawy Y, Dobbs D, Honavar V. Predicting linear B-cell epitopes using string kernels. J Mol Recognit. 2008; 21(4): 243-55[DOI][PubMed]
  • 17. Ansari HR, Raghava GP. Identification of conformational B-cell Epitopes in an antigen from its primary sequence. Immunome Res. 2010; 6: 6[DOI][PubMed]
  • 18. Haste Andersen P, Nielsen M, Lund O. Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci. 2006; 15(11): 2558-67[DOI][PubMed]
  • 19. Singh H, Raghava GP. ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics. 2003; 19(8): 1009-14[PubMed]
  • 20. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics. 2001; 17(12): 1236-7[PubMed]
  • 21. Ivanciuc O, Schein CH, Braun W. SDAP: database and computational tools for allergenic proteins. Nucleic Acids Res. 2003; 31(1): 359-62[PubMed]
  • 22. Davis GD, Elisee C, Newham DM, Harrison RG. New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol Bioeng. 1999; 65(4): 382-8[PubMed]
  • 23. Ren J, Wen L, Gao X, Jin C, Xue Y, Yao X. DOG 1.0: illustrator of protein domain structures. Cell Res. 2009; 19(2): 271-3[DOI][PubMed]
  • 24. De Groot AS, Sbai H, Aubin CS, McMurry J, Martin W. Immuno-informatics: Mining genomes for vaccine components. Immunol Cell Biol. 2002; 80(3): 255-69[DOI][PubMed]
  • 25. He Y, Cao Z, De Groot AS, Brusic V, Schonbach C, Petrovsky N. Computational vaccinology and the ICoVax 2012 workshop. BMC Bioinformatics. 2013; 14 Suppl 4[DOI][PubMed]
  • 26. Arai R, Wriggers W, Nishikawa Y, Nagamune T, Fujisawa T. Conformations of variably linked chimeric proteins evaluated by synchrotron X-ray small-angle scattering. Proteins. 2004; 57(4): 829-38[DOI][PubMed]
  • 27. Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 2001; 14(8): 529-32[PubMed]
  • 28. Soria-Guerra RE, Moreno-Fierros L, Rosales-Mendoza S. Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches. Plant Cell Rep. 2011; 30(8): 1367-82[DOI][PubMed]
  • 29. Webb B, Sali A. Comparative Protein Structure Modeling Using MODELLER. Curr Protoc Bioinformatics. 2014; 47: 5 6 1-5 6 32[DOI][PubMed]
  • 30. Petsko GA. An introduction to modeling structure from sequence. Curr Protocols Bioinform. 2006; : 5.1. 1-3
  • 31. Negi SS, Braun W. Automated detection of conformational epitopes using phage display Peptide sequences. Bioinform Biol Insights. 2009; 3: 71-81[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments